Drugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss. Another medication in the same class has impressed in a recent phase 2 clinical trial – and it only ...

Post the FDA approval, patients have the option to transition to a monthly maintenance dosing regimen of Leqembi after completing an 18-month course of biweekly infusions of the drug.